Clinical Trial Update: Fresolimumab and Radiotherapy in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fresolimumab in combination with radiotherapy for metastatic breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fresolimumab (Fresolimumab)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-04-06